RS 25259

Known as: RS-25259 
 
National Institutes of Health

Topic mentions per year

Topic mentions per year

1995-1998
01219951998

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
1999
1999
  • Drugs in R&D
  • 1999
 
Is this relevant?
1998
1998
UNLABELLED We evaluated the safety and efficacy of RS-25259, a potent and long-acting selective 5-HT3 receptor antagonist, for… (More)
Is this relevant?
Highly Cited
1995
Highly Cited
1995
1. A series of isoquinolines have been identified as 5-HT3 receptor antagonists. One of these, RS 25259-197 [(3aS)-2-[(S)-1… (More)
Is this relevant?
1995
1995
1. The pharmacological effects in vivo, of RS 25259-197, a selective 5-HT3 receptor antagonist, have been investigated. 2. In… (More)
Is this relevant?